LXRX - Lexicon Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$6.00
DETAILS
HIGH:
$6.00
LOW:
$6.00
MEDIAN:
$6.00
CONSENSUS:
$6.00
UPSIDE:
177.78%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 7,814,606 | $12.2M | 0.0% | +7,530,581 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-30 | Artal Participations S.a r.l. | director, 10 percent owner: | M-Exempt | 20,421,735 | -- | -- |
| 2026-04-30 | Artal Participations S.a r.l. | director, 10 percent owner: | A-Award | 408,434 | -- | -- |
| 2026-04-30 | Artal Participations S.a r.l. | director, 10 percent owner: | M-Exempt | 408,434 | -- | -- |
| 2026-05-01 | Amouyal Philippe | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | Amouyal Philippe | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | SOBECKI CHRISTOPHER J | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | SOBECKI CHRISTOPHER J | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | BARKER SAM L | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | BARKER SAM L | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | Cheung Ivan | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | Cheung Ivan | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | Swain Judith L | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | Sullivan Diane E. | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | DEBBANE RAYMOND | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | DEBBANE RAYMOND | director | A-Award | 43,478 | $1.61 | $70K |
| 2026-05-01 | Sullivan Diane E. | director | A-Award | 35,714 | -- | -- |
| 2026-05-01 | Swain Judith L | director | A-Award | 35,714 | -- | -- |
| 2026-02-28 | Gopinathan Suma | officer: SVP, Discovery | M-Exempt | 65,640 | -- | -- |
| 2026-02-28 | Coiante Scott M | officer: SVP, Chief Financial Officer | F-InKind | 54,881 | $1.47 | $81K |
| 2026-02-28 | DeFrancesco Lisa | officer: SVP, IR and Corp Comm | M-Exempt | 128,190 | -- | -- |
| 2026-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | M-Exempt | 170,163 | -- | -- |
| 2026-02-28 | Gopinathan Suma | officer: SVP, Discovery | F-InKind | 24,338 | $1.47 | $36K |
| 2026-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | F-InKind | 105,019 | $1.47 | $154K |
| 2026-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | F-InKind | 109,098 | $1.47 | $160K |
| 2026-02-28 | Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | M-Exempt | 67,090 | -- | -- |